methylprednisolone has been researched along with Cognitive Decline in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 7 (46.67) | 24.3611 |
| 2020's | 8 (53.33) | 2.80 |
| Authors | Studies |
|---|---|
| Che, NN; Chen, SY; Li, X; Ma, JJ; Yang, HQ | 1 |
| Abu-Salameh, I; Gadoth, A; Horev, A; Ifergane, G; Novoa, R; Zlotnik, Y | 1 |
| Alves, JN; Carvalho, R; Dias, L; Marques, S; Matos, AR; Oliveira, AI; Quintas-Neves, M | 1 |
| Acharya, S; Adhikari, A; Paudel, R; Subedi, RC | 1 |
| Garrels, E; Huq, F; McKay, G | 1 |
| Attwood, JE; Michael, S; Naseer, S; Riley, J | 1 |
| Day, GS; Fagan, AM; Henson, RL; Morris, JC; Plotzker, AS | 1 |
| Gofshteyn, JS; Gourley, D; Grinspan, Z; J, JL; K, KG; Marquis, BO; Nangia, S | 1 |
| Guo, ZK; Kong, FX; Lu, QH | 1 |
| Kishida, D; Miyazaki, D; Sato, M; Sekijima, Y | 1 |
| Ceanga, M; Chung, HY; Geis, C; Sell, J; Voss, A; Wickel, J; Witte, OW | 1 |
| Bailey, M; Gera, A; Witek, N | 1 |
| Elia, M; Huang, J | 1 |
| Ammar, HM; Appel, SE; Cooper, BL | 1 |
| Afshari, M; Afshari, ZS; Schuele, SU | 1 |
15 other study(ies) available for methylprednisolone and Cognitive Decline
| Article | Year |
|---|---|
Autoimmune-mediated secondary-parkinsonism presented with micrographia and cognitive impairment.
Topics: Adult; Anti-N-Methyl-D-Aspartate Receptor Encephalitis; Antiparkinson Agents; Autoantibodies; Benserazide; Cognitive Dysfunction; Drug Combinations; Fever of Unknown Origin; Handwriting; Humans; Immunosuppressive Agents; Immunotherapy; Levodopa; Male; Methylprednisolone; Neuropsychological Tests; Parkinson Disease, Secondary; Tremor | 2021 |
Case Report: Anti-LGI1 Encephalitis Following COVID-19 Vaccination.
Topics: Autoantibodies; Autoimmune Diseases; BNT162 Vaccine; Cognitive Dysfunction; COVID-19; Encephalitis; Glucocorticoids; Humans; Hyponatremia; Intracellular Signaling Peptides and Proteins; Male; Methylprednisolone; Middle Aged; Prednisone; SARS-CoV-2; Treatment Outcome; Vaccination | 2021 |
COVID-19 Associated Central Nervous System Vasculopathy.
Topics: Adult; Angiography, Digital Subtraction; Basal Ganglia; Cerebral Angiography; Cerebrovascular Disorders; Cognitive Dysfunction; COVID-19; COVID-19 Drug Treatment; Deglutition Disorders; Diffusion Magnetic Resonance Imaging; Dysphonia; Emergency Service, Hospital; Executive Function; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Magnetic Resonance Imaging; Male; Methylprednisolone; Patient Discharge; Pons; Posterior Cerebral Artery; SARS-CoV-2; Severity of Illness Index; Thalamus; Tomography, X-Ray Computed; White Matter | 2021 |
Anti-leucine-rich Glioma-inactivated-1 Encephalitis with Faciobrachial Dystonic Seizures and Behavioral Problems: A Case Report.
Topics: Anticonvulsants; Autoantibodies; Autoimmune Diseases of the Nervous System; Cognitive Dysfunction; Dystonic Disorders; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Intracellular Signaling Peptides and Proteins; Limbic Encephalitis; Magnetic Resonance Imaging; Male; Mental Disorders; Methylprednisolone; Middle Aged; Nepal; Problem Behavior; Seizures | 2020 |
Voltage-gated potassium channel limbic encephalitis presenting as functional cognitive impairment.
Topics: Anti-Inflammatory Agents; Autoantibodies; Cognitive Dysfunction; Confusion; Delusions; Diagnosis, Differential; Hallucinations; Humans; Immunoglobulins, Intravenous; Limbic Encephalitis; Male; Methylprednisolone; Middle Aged; Potassium Channels, Voltage-Gated | 2020 |
Clinical diagnosis of LGI1 antibody encephalitis in an 83-year-old woman.
Topics: Administration, Intravenous; Aged, 80 and over; Autoantibodies; Cognitive Dysfunction; Female; Glucocorticoids; Humans; Immunotherapy; Intracellular Signaling Peptides and Proteins; Limbic Encephalitis; Limbic System; Methylprednisolone; Plasma Exchange; Positron-Emission Tomography; Seizures; Treatment Outcome | 2021 |
Clinical and Paraclinical Measures Associated with Outcome in Cerebral Amyloid Angiopathy with Related Inflammation.
Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Anti-Inflammatory Agents; Biomarkers; Cerebral Amyloid Angiopathy; Cognitive Dysfunction; Critical Care; Electroencephalography; Encephalitis; Female; Humans; Leukocytosis; Longitudinal Studies; Magnetic Resonance Imaging; Male; Methylprednisolone; Neuroimaging; Peptide Fragments; tau Proteins; Treatment Outcome | 2021 |
Measurable outcomes for pediatric epileptic encephalopathy: a single-center experience with corticosteroid therapy.
Topics: Adolescent; Adrenal Cortex Hormones; Brain Waves; Child; Child, Preschool; Cognitive Dysfunction; Dexamethasone; Drug Resistant Epilepsy; Electroencephalography; Female; Humans; Infant; Male; Methylprednisolone; Outcome Assessment, Health Care; Retrospective Studies; Seizures | 2021 |
Multiple intracranial lesions as the unusual imaging features of Hashimoto's encephalopathy: A case report.
Topics: Administration, Intravenous; Autoantibodies; Brain Diseases; Cognitive Dysfunction; Dizziness; Electroencephalography; Encephalitis; Female; Gait Disorders, Neurologic; Glucocorticoids; Hashimoto Disease; Humans; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Tomography, X-Ray Computed; Treatment Outcome | 2018 |
A Patient with Limbic Encephalitis Associated with Anti-leucine-rich Glioma-inactivated 1 (LGI1) Antibody Presenting with Slowly Progressive Cognitive Impairment and Fluctuating Striatal Lesions.
Topics: Administration, Intravenous; Anti-Inflammatory Agents; Autoantibodies; Brain; Cognitive Dysfunction; Dementia; Diagnosis, Differential; Disease Progression; Humans; Intracellular Signaling Peptides and Proteins; Leucine; Limbic Encephalitis; Magnetic Resonance Imaging; Male; Methylprednisolone; Middle Aged; Prednisolone; Proteins; Seizures | 2019 |
Autoimmune encephalitis with anti-IgLON5 and anti-GABAB-receptor antibodies: A case report.
Topics: Administration, Intravenous; Autoantibodies; Cell Adhesion Molecules, Neuronal; Cognitive Dysfunction; Cyclophosphamide; Depressive Disorder; Dysarthria; Encephalitis; GABA-B Receptor Antagonists; Gait Disorders, Neurologic; Glucocorticoids; Hallucinations; Hashimoto Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Plasmapheresis; Sleep Wake Disorders; Treatment Outcome | 2019 |
Pearls & Oy-sters: CAA-related inflammation presents as subacute cognitive decline in a patient with Parkinson disease.
Topics: Aged; Brain Edema; Cerebral Amyloid Angiopathy; Cognitive Dysfunction; Frontal Lobe; Glucocorticoids; Humans; Inflammation; Magnetic Resonance Imaging; Male; Methylprednisolone; Parkinson Disease; White Matter | 2019 |
Decreased Vision and Cognitive Decline.
Topics: Adult; Antibiotics, Antineoplastic; Cognitive Dysfunction; Cyclosporine; Drug Therapy, Combination; Fluorescein Angiography; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Lupus Erythematosus, Systemic; Male; Methylprednisolone; Mycophenolic Acid; Retinal Vasculitis; Vision, Low; Visual Acuity | 2016 |
A young female with urinary retention - Hashimoto's Encephalopathy.
Topics: Adult; Cognitive Dysfunction; Encephalitis; Female; Hashimoto Disease; Humans; Methylprednisolone; Urinary Retention | 2017 |
Pearls & oy-sters: Hashimoto encephalopathy.
Topics: Adrenal Cortex Hormones; Adult; Anticonvulsants; Autoantibodies; Brain Diseases; Cognitive Dysfunction; Diagnosis, Differential; Drug Administration Schedule; Early Diagnosis; Electroencephalography; Encephalitis; Epilepsy, Generalized; Fatal Outcome; Female; Hashimoto Disease; Humans; Methylprednisolone; Plasmapheresis; Prednisone; Rare Diseases; Seizures; Thyroid Gland; Thyrotropin; Time Factors; Treatment Failure; Video Recording | 2012 |